Abstract:AIM: To characterize the effect of different oral formulations on the metabolism, excretion and bioavailability of hydroxysafflor yellow A (HSYA). METHODS: HSYA lipid-based formulation and aqueous solution were prepared and orally adminis-tered to rats. A gradient HPLC and LC-MS method was performed to determine HSYA concentration in rat serum, bile, urine and feces samples. RESULTS: The bile sample digestion test combining HPLC with LC-MS proved the existence of HSYA and phase Ⅱ metabolites in bile for both formulations. Their protonated molecular ions at m/z 918 and m/z 691 indicated that the metabolites were glutathione and sulfate conjugate, according to the protonated molecular ions of HSYA at m/z 611. The amount of the two metabolites and HSYA excreted from bile was significantly decreased for the lipid-based formulation, compared with that of the aqueous solution.The amount of parent component, HSYA, in bile, feces and urine in 24 h was (0.05 ± 0.03)%, (8.80 ± 2.30)% and (37.99 ± 17.50)% for the lipid-based formulation. For the aqueous solution, the amount of HSYA excreted in bile, feces and urine in 24 h was (0.32±0.22)%, (44.66± 8.00)% and (5.58 ± 1.30)%,respectively. Compared with the Cmax of 0.08 μg·mL-1 and AUC0-8h of 10.73 μg·min-mL-1 for HSYA aqueous solution, the Cmax and AUC0-8 h of HSYA lipid-based formulation were significantly increased up to 2.79 μg·mL-1 and 402.51 μg·min·mL-1. CONCLUSION: The results suggested that the lipid-based formulation may not alter the phase Ⅱ metabolism mechanism of HSYA but significantly decreased HSYA excretion from bile and feces so as to enhance the bioavailability and absorption.

Studies on Pharmacokinetics of Carthami Flos and Hydrosafflor Yellow A in Rats

[Pharmacokinetic Effect of Sappan Lignum on Hydroxysafflor Yellow A in Carthami Flos].

Effects of Radix Glycyrrhizae on the Pharmacokinetics of Hydroxysafflor Yellow A in Carthamus Tinctorius L.

A Comprehensive in Vitro and in Vivo Metabolism Study of Hydroxysafflor Yellow A

Study of screening nephroprotective bioactive substances based on triple-color fluorescence probes in Carthami Flos

Effects of Sappan Lignum on Pharmacokinetics of Hydroxysafflor Yellow A from Carthami Flos in Rats with Cold Coagulation and Blood Stasis

The Safety, Tolerability, and Pharmacokinetics of Active Ingredients From Hydroxysafflor Yellow A in Healthy Chinese Volunteers

Metabolism, Excretion and Bioavailability of Hydroxysafflor Yellow A after Oral Administration of Its Lipid-Based Formulation and Aqueous Solution in Rats

[Pharmacokinetical Study of Safflor Yellow on Rat Acute Model of Blood Stasis Syndrome].

Pharmacokinetics of Hydroxysafflor Yellow A in Rats

Rapid Screening and Identification of Anticoagulation Component from Carthami Flos by Two-Dimensional Thrombin Affinity Chromatography Combined with HPLC-MS/MS.

Research on technological process of two-pot countercurrent extraction of hydroxysafflor yellow A

Development and Validation of a UFLC–MS/MS Method for the Determination of Anhydrosafflor Yellow B in Rat Plasma and Its Application to Pharmacokinetic Study

Simultaneous Determination of Hydroxysafflor Yellow A and Ferulic Acid in Rat Plasma after Oral Administration of the Co-Extractum of Rhizoma Chuanxiong and Flos Carthami by Hplc-Diode Array Detector

Investigation on the Absorption Kinetics of Chlorogenic Acid in Rats by HPLC.

Carthami flos : a review of its ethnopharmacology, pharmacology and clinical applications

Absorption Mechanism of Hydroxysafflor Yellow A in Rats

Hydroxysafflor Yellow A: A Systematical Review on Botanical Resources, Physicochemical Properties, Drug Delivery System, Pharmacokinetics, and Pharmacological Effects

Solid Lipid Nanoparticles As Carriers for Oral Delivery of Hydroxysafflor Yellow A.

Uptake and Transport of Hydroxysafflor Yellow A in Caco-2 Cells Monolayer

HPLC Analysis of the Hydroxysafflor Yellow A in Excretion of Rat